Literature DB >> 1316735

9-(Phosphonoalkyl)guanine derivatives as substrates or inhibitors of guanylate kinase.

J F Navé1, A Eschbach, S Halazy.   

Abstract

Several 9-(phosphonoalkyl)guanines (Gua(CH2)nCH2-PO3H2; n = 4-6) and 9-(difluorophosphonoalkyl)guanines (Gua(CH2)nCF2PO3H2; n = 3-7) were studied as potential substrates and inhibitors of guanylate kinase. These compounds are inhibitors of the enzyme except 9-(5-phosphonopentyl)guanine (n = 4) which is a substrate with an efficiency of phosphorylation of about 0.3% that of GMP, as estimated from the Vmax/Km ratios. The phosphonate and difluorophosphonate derivatives with n = 5 produce optimal inhibition. These two compounds have similar affinity, both being competitive inhibitors with respect to GMP and noncompetitive inhibitors with respect to ATP. pH-dependence studies indicate that the dianionic rather than the monoanionic form of these compounds bind to the enzyme. The lack of phosphorylation of 9-(5,5-difluoro-5-phosphonopentyl)guanine by guanylate kinase is explained by the decreased nucleophilic character of the oxygen atoms of the phosphonate group rather than by inadequate binding to the GMP-binding site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316735     DOI: 10.1016/0003-9861(92)90515-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Solution structure and functional investigation of human guanylate kinase reveals allosteric networking and a crucial role for the enzyme in cancer.

Authors:  Nazimuddin Khan; Parag P Shah; David Ban; Pablo Trigo-Mouriño; Marta G Carneiro; Lynn DeLeeuw; William L Dean; John O Trent; Levi J Beverly; Manfred Konrad; Donghan Lee; T Michael Sabo
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

2.  FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2.

Authors:  Alina Renz; Lina Widerspick; Andreas Dräger
Journal:  Bioinformatics       Date:  2020-12-30       Impact factor: 6.937

3.  Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target.

Authors:  Alina Renz; Lina Widerspick; Andreas Dräger
Journal:  Genes (Basel)       Date:  2021-05-24       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.